BREAKINGMulti-SourceHims & Hers is a brave bet on solving the disruptor’s dilemmaFinancial Times|2/15/2026
UNVERIFIEDSingle SourceStocks making the biggest moves midday: Oracle, Cleveland-Cliffs, Nexstar, Workday, Hims & HersCNBC|2/9/2026
UNVERIFIEDSingle SourceStocks making the biggest moves premarket: Oracle, Novo Nordisk, Hims & Hers Health, Kroger and moreCNBC|2/9/2026
UNVERIFIEDSingle SourceHims & Hers abandons copycat weight-loss drug in face of FDA probeFinancial Times|2/7/2026
UNVERIFIEDSingle SourceHHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy - statnews.comStat News|2/7/2026
UNVERIFIEDSingle SourceUS signals crackdown on compounded weight-loss drugs; Hims shares tumbleReuters|2/6/2026
UNVERIFIEDSingle SourceHims & Hers' $49 weight-loss pill jolts everyone, except its stockReuters|2/6/2026
UNVERIFIEDSingle SourceHims offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, LillyReuters|2/5/2026